Page last updated: 2024-08-21

paraquat and cilostazol

paraquat has been researched along with cilostazol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akishita, M; Eto, M; Iijima, K; Kano, MR; Ogawa, S; Ota, H; Ouchi, Y1

Other Studies

1 other study(ies) available for paraquat and cilostazol

ArticleYear
Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells.
    Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:9

    Topics: Acetylation; Animals; Benzamides; Cell Shape; Cells, Cultured; Cellular Senescence; Cilostazol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Mice; Mice, Inbred BALB C; Naphthols; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidants; Oxidative Stress; Paraquat; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Phosphorylation; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Sirtuin 1; Sirtuins; Tetrazoles; Time Factors; Tumor Suppressor Protein p53; Up-Regulation

2008